{"title":"Toward once-monthly insulin therapy via synergy in two pharmacokinetic protractors: Fc-conjugation and fatty acid acylation","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/CB/D4CB00078A","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4CB00078A\" /></p></div><div><i><b>RSC Chem. Biol.</b></i>, 2024, <b>5</b>,763-775<br /><b>DOI</b>: 10.1039/D4CB00078A, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png\" alt=\"Creative Commons Licence\" /></a>  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\">Creative Commons Attribution 3.0 Unported Licence.</a></div><div>Alexander N. Zaykov, Vasily M. Gelfanov, Tina M. Tagmose, Damien Demozay, Valentina Manfè, Rebecca Rohlfs, Marita Rivir, Diego Perez-Tilve, Brian Finan, Richard D. DiMarchi<br />Pharmacokinetic properties of a peptide hormone are extended <em>via</em> the combination of fatty acid acylation and Fc-conjugation, as shown with double protracted insulin analogs. This approach may be expanded to other peptide- and protein-based therapies.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Chem. Biol. latest articles","siteHash":"1843dfbfc0bf39b0fe9743f763f2ba4e6cb90d9c3732ca303b2e6e5daeb3deb0","entryHash":"dd9bfe906c172167eb924502a14acda83c71b0ff5155fa2f9f61c6bd12768852","category":"Environment"}